FAQ

Traditional cancer treatments include surgery, chemotherapy, radiation therapy, and targeted drugs. These treatments often come with significant side effects, which can be irreversible for cancer patients. After treatment, patients may require a long recovery period, which can impact their quality of life.
Immunocellular therapy, also known as a non-toxic and non-invasive cancer treatment method, involves using the patient's cultured blood. Immune cells are isolated through immunotherapy technology, then cultured, expanded, and activated outside the body, and finally reinfused into the patient to attack cancer cells. This approach has minimal side effects and helps maintain the patient's quality of life.

Generally, immunotherapy refers to the use of immune checkpoint inhibitors or immune drugs, which is completely different from immunocellular therapy.
Immunotherapy: works by targeting PD-L1, a protein that cancer cells release to disguise themselves as normal cells, making them undetectable to the immune system. Immune drugs block the action of PD-L1, allowing the immune system to recognize and attack cancer cells. However, forcibly blocking PD-L1 can cause immune cells to indiscriminately attack normal cells, leading to irreversible autoimmune diseases.
Immunocellular therapy: relatively mild. It involves extracting the patient's blood, isolating immune cells using immunocellular technology, then cultivating, expanding, and activating them outside the body before reinfusing them into the patient to target and kill cancer cells. This approach has minimal side effects and helps maintain the patient's quality of life.

cells in the body, why does recurrence happen? -
Cancer cells are very tricky and can easily hide. Many patients endure the side effects of cancer treatment and various physical discomforts, and although tests may show that the cancer cells have been completely eliminated, they can still hide in areas undetectable by instruments, waiting for an opportunity to reemerge.
Lukas Biomedical's immunocellular therapy employs "Memory T cells" which possess specific immune memory. These cells can survive in the body for over a year, continuously circulating and monitoring for cancer cells. Upon encountering cancer cells, they promptly initiate an attack, effectively helping to prevent recurrence and maintain control over the disease.

Each biotech company has its own immune cell culture techniques, each with its pros and cons. The table below lists the common immune cells and their advantages in cancer treatment：

Cancer tumors are highly personalized diseases. Even when using the same treatment for cancers of the same type and stage, the treatment efficacy varies from person to person. Cancer treatment is a long-term and complex process. Upon discovering cancer, it is crucial to follow a professional physician's recommendation for combined therapy, utilizing all available treatment options to maximize effectiveness.
Immunocellular therapy can be combined with various treatment methods to address the immune deficiency and low white blood cell count caused by common treatments. This therapy provides robust support and additional anti-cancer weaponry during the cancer treatment process. Additionally, it can be used after traditional treatments to target residual or undetectable cancer cells, helping to prevent recurrence.

Immunocellular therapy is not only suitable to patients in the late stages (Stage IV), but it is actually more effective when used earlier. Many patients begin immunocellular therapy only after reaching an advanced stage and developing drug resistance, by which time their bodies have been heavily impacted by chemical or destructive treatments, and they have been told that there are no further treatment options. While some patients may achieve stable disease control, a few experience organ failure or ascites, and the immune cells do not have time to react, leading to unfortunate outcomes. If immunocellular therapy can be introduced earlier in combination with other treatments, it can achieve better results by seizing the golden period for optimal treatment.

In medical terms, cancer treatment primarily focuses on the five-year survival rate rather than the cure rate.
Achieving effective control to prevent recurrence and metastasis while maintaining the patient's quality of life is the primary goal of immunocellular therapy. It is also the main reason why many cancer patients choose this therapy.

Below are the statistical results of Lukas Biomedical's memory T cells under Taiwan's Administrative Regulation on Special Medical Instruments and Inspection Techniques:

Immunocellular therapy is currently a self-funded medical treatment and is not yet covered by health insurance.
The eligibility for commercial medical insurance claims depends on the insurance policy and coverage limits of the patient. Usually, cancer insurance, medical expense reimbursement insurance, and hospitalization insurance may be eligible for claims.

The costs for immunocellular therapy are fully disclosed under the government’s special administrative measures and are considered legitimate medical procedures. The fees may vary slightly depending on the hospital partnering with Lukas Biomedical. You can refer to the publicly available cell therapy fee information provided by the Ministry of Health and Welfare under these special administrative measures:
https://celltherapy.mohw.gov.tw/tech_search.htm 

If you want to schedule a consultation, you can use the following methods：
✍ Leave your contact information：https://www.lukas-biomedical.com/contact/　
📑 Send a message via Facebook：https://www.facebook.com/lukas.bio.corp/　
🤳 Send a message via LINE@ official account：https://page.line.me/?accountId=061buhws　
☎️ Tel：02-29500027#305